[1] Nicoll R A. A brief history of long-term potentiation[J]. Neuron, 2017, 93(2):281
[2] Guntupalli S, Widagdo J, Anggono V. Amyloid-beta-induced dysregulation of AMPA receptor trafficking[J].Neural Plast, 2016, 2016:3204519
[3] Granger A J, Shi Y, Lu W, et al. LTP requires a reserve pool of glutamate receptors independent of subunit type[J]. Nature, 2013, 493 (7433):495
[4] Hosokawa T, Mitsushima D, Kaneko R, et al. Stoichiometry and phosphoisotypes of hippocampal AMPA-type glutamate receptor phosphorylation[J]. Neuron, 2015, 85(1):60
[5] Rodrigues E M, Scudder S L, Goo M S. A beta-induced synaptic alterations require the E3 ubiquitin ligase Nedd4-1[J]. J Neurosci, 2016, 36(5):1590
[6] Radin D P, Zhong S, Purcell R, et al. Acute ampakine treatment ameliorates age-related deficits in long-term potentiation[J]. Biomed Pharmacother, 2016, 84,806
[7] Hara Y, Punsoni M, Yuk F, et al. Synaptic distributions of GluA2 and PKM zeta in the monkey dentate gyrus and their relationships with aging and memory[J]. J Neurosci, 2012,32(21):7336
[8] Knafo S, Sanchez-Puelles C, Palomer E A, et al. PTEN recruitment controls synaptic and cognitive function in Alzheimer’s models[J]. Nat Neurosci, 2016, 19(3):443
[9] Li S M, Jin M, Koeglsperger T, et al. Soluble a beta oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-Containing NMDA receptors[J]. J Neurosci, 2011, 31(18):6627
[10] Tu S C, Okamoto S I, Lipton S A, et al. Oligomeric a beta-induced synaptic dysfunction in alzheimer’s disease[J]. Mol Neurodegener, 2014, 9:48
[11] Watts J C, Prusiner S B. β-Amyloid prions and the pathobiogy of alzheimer’s disease[J]. Cold Spring Harb Perspect Med, 2018, 8(5): pii: a023507
[12] Rahman M M, Zetterberg H, Lendel C A. Binding of human proteins to amyloid-beta protofibrils[J]. ACS Chem Biol, 2015, 10(3):766
[13] Reinders N R, Pao Y, Renner M C, et al. Amyloid-beta effects on synapses and memory require AMPA receptor subunit GluA3[J]. Proc Natl Acad Sci U S A, 2016, 113(42):E6526
[14] Alfonso S, Kessels H W, Banos C C, et al. Synapto-depressive effects of amyloid beta require PICK1[J]. Eur J Neurosci, 2014, 39(7):1225
[15] Berchtold N C, Sabbagh M N, Beach T G, et al. Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer’s disease[J]. Neurobiol Aging, 2014, 35(9):1961
[16] Granger A J, Shi Y, Lu W, et al. LTP requires a reserve pool of glutamate receptors independent of subunit type[J]. Nature, 2013, 493(7433):495
[17] Whitcomb D J, Hogg E L, Regan P, et al. Intracellular oligomeric amyloid-beta rapidly regulates GluA1 subunit of AMPA receptor in the hippocampus[J]. Sci Rep,2015,5:10934
[18] Wirth M, Madison C M, Rabinovici G D, et al. Alzheimer’s disease neurodegenerative biomarkers are associated with decreased cognitive function but not beta-amyloid in cognitively normal older individuals[J]. J Neurosci, 2013, 33(13):5553
[19] Yu W D, Polepalli J, Wagh D, et al. A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of A on synapses and dendritic spines[J]. Hum Mol Genet, 2012,21(6):1384
[20] Kopeikina K J, Polydoro M, Tai H , et al. Synaptic alterations in the rTg4510 mouse model of tauopathy[J]. J Comp Neurol, 2013, 521(6):1334
[21] Fa M, Puzzo D, Piacentini R, et al. Extracellular Tau oligomers produce an immediate impairment of LTP and memory[J]. Sci Rep, 2016, 6:19393
[22] Regan P, Piers T, Yi J H, et al. Tau phosphorylation at serine 396 residue is required for hippocampal Ltd[J]. J Neurosci, 2015, 35(12):4804
[23] Ittner A, Chua S W, Bertz J, et al. Site-specific phosphorylation of tau inhibits amyloid-beta toxicity in Alzheimer’s mice[J]. Science, 2016, 354(6314):904
[24] Tracy T E, Gan L. Acetylated tau in Alzheimer’s disease: an instigator of synaptic dysfunction underlying memory loss: increased levels of acetylated tau blocks the postsynaptic signaling required for plasticity and promotes memory deficits associated with tauopathy[J]. Bioessays, 2017, 39(4): doi: 10.1002/bies.201600224
[25] Tracy T E, Sohn P D, Minami S S, et al. Acetylated Tau obstructs KIBRA-mediated signaling in synaptic plasticity and promotes Tauopathy-Related memory loss[J]. Neuron, 2016, 90(2):245
[1]姜明月,于敏,李文,等.叶酸对N2a-APP695细胞Tau蛋白及其Ser396位点磷酸化的调控[J].天津医科大学学报,2013,19(05):365.
[2]付雪斐,李 靖,孙凤仙,等.β片层阻断肽对AD模型小鼠学习记忆及PI3K/AKT信号通路的影响[J].天津医科大学学报,2016,22(05):391.
FU Xue-fei,LI Jing,SUN Feng-xian,et al. Effect of β-sheet breaker peptide on learning and memory and PI3K /AKT? signaling pathway in AD model mice ? [J].Journal of Tianjin Medical University,2016,22(03):391.
[3]陈文博,寇亚芬,张引国,等.贝沙罗汀拮抗Aβ25-35诱导的海马CA1区锥体神经元谷氨酸能突触传递的抑制效应[J].天津医科大学学报,2017,23(04):285.
CHEN Wen-bo,KOU Ya-fen,ZHANG Yin-guo,et al.Antagonistic effect of bexarotene on Aβ25-35 -Induced inhibiting action in glutamatergic synaptic transmission of hippocampal CA1 pyramidal neurons[J].Journal of Tianjin Medical University,2017,23(03):285.
[4]孙凤仙,徐淑梅.H102-BD经鼻腔给药后对双转基因AD小鼠行为学及脑内APP和Aβ蛋白表达的影响[J].天津医科大学学报,2017,23(05):385.
SUN Feng-xian,XU Shu-mei.Effect of H102-BD on behavior and the expression of APP and Aβ in PAP double transgenic AD mice after intranasal administration[J].Journal of Tianjin Medical University,2017,23(03):385.
[5]孙晓倩 综 述,吴 伟 审 校.睡眠剥夺与中枢神经系统疾病关系的研究进展[J].天津医科大学学报,2018,24(05):461.
[6]司蕊豪,刘羽茜,朱仲康,等.基于生信分析对阿尔茨海默病炎症相关关键基因的筛选及鉴定[J].天津医科大学学报,2023,29(05):486.
SI Rui-hao,LIU Yu-xi,ZHU Zhong-kang,et al.Screening and identification of key genes associated with Alzheimer′s disease inflammation based on bioinformatics analysis[J].Journal of Tianjin Medical University,2023,29(03):486.